| Authors: |
Hyams C; Population Health Sciences, University of Bristol, Bristol, UK. Electronic address: catherine.hyams@bristol.ac.uk., Lahuerta M; Pfizer Vaccines, Collegeville, PA, USA., Theilacker C; Pfizer Vaccines, Collegeville, PA, USA., King J; Clinical Research and Imaging Centre, UHBW NHS Trust, Bristol, UK., Adegbite D; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, Bristol, UK., McGuinness S; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, Bristol, UK., Grimes C; North Bristol NHS Trust, Bristol, UK., Campling J; Vaccines Medical Affairs, Pfizer Ltd, Surrey, UK., Southern J; Pfizer Vaccines, Collegeville, PA, USA., Pride MW; Vaccine Research and Development, Pfizer Research, NY, USA., Begier E; Pfizer Vaccines, Collegeville, PA, USA., Maskell N; Academic Respiratory Unit, University of Bristol, Bristol, UK., Oliver J; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, Bristol, UK., Jodar L; Pfizer Vaccines, Collegeville, PA, USA., Gessner BD; Pfizer Vaccines, Collegeville, PA, USA., Finn A; Bristol Vaccine Centre, Cellular and Molecular Medicine and Population Health Sciences, University of Bristol, Bristol, UK. |
